These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34077538)

  • 1. A Model Template Approach for Rapid Evaluation and Application of Physiologically Based Pharmacokinetic Models for Use in Human Health Risk Assessments: A Case Study on Per- and Polyfluoroalkyl Substances.
    Bernstein AS; Kapraun DF; Schlosser PM
    Toxicol Sci; 2021 Aug; 182(2):215-228. PubMed ID: 34077538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Model Template Approach for Rapid Evaluation and Application of Physiologically Based Pharmacokinetic Models: Extension to Volatile Organic Compounds.
    Bernstein AS; Prasad B; Schlosser PM; Kapraun DF
    Toxicol Sci; 2023 Mar; ():. PubMed ID: 36869685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.
    Peters SA
    Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PBPK model reporting template for chemical risk assessment applications.
    Tan YM; Chan M; Chukwudebe A; Domoradzki J; Fisher J; Hack CE; Hinderliter P; Hirasawa K; Leonard J; Lumen A; Paini A; Qian H; Ruiz P; Wambaugh J; Zhang F; Embry M
    Regul Toxicol Pharmacol; 2020 Aug; 115():104691. PubMed ID: 32502513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
    Peters SA
    Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of Toxicogenomics and Physiologically Based Pharmacokinetic Modeling in Human Health Risk Assessment of Perfluorooctane Sulfonate.
    Chen Q; Chou WC; Lin Z
    Environ Sci Technol; 2022 Mar; 56(6):3623-3633. PubMed ID: 35194992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
    Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N
    Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based pharmacokinetic model use in risk assessment--Why being published is not enough.
    McLanahan ED; El-Masri HA; Sweeney LM; Kopylev LY; Clewell HJ; Wambaugh JF; Schlosser PM
    Toxicol Sci; 2012 Mar; 126(1):5-15. PubMed ID: 22045031
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kamiya Y; Handa K; Miura T; Yanagi M; Shigeta K; Hina S; Shimizu M; Kitajima M; Shono F; Funatsu K; Yamazaki H
    Chem Res Toxicol; 2021 Feb; 34(2):507-513. PubMed ID: 33433197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
    Frechen S; Rostami-Hodjegan A
    Pharm Res; 2022 Aug; 39(8):1733-1748. PubMed ID: 35445350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).
    Mumtaz MM; Ray M; Crowell SR; Keys D; Fisher J; Ruiz P
    J Toxicol Environ Health A; 2012; 75(1):6-24. PubMed ID: 22047160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: A bottom up modeling approach.
    Sharma RP; Schuhmacher M; Kumar V
    Toxicol Lett; 2018 Oct; 296():152-162. PubMed ID: 29958929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation.
    Ellison CA
    Regul Toxicol Pharmacol; 2018 Nov; 99():61-77. PubMed ID: 30201539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling.
    Li GF; Wang K; Chen R; Zhao HR; Yang J; Zheng QS
    Acta Pharmacol Sin; 2012 Nov; 33(11):1359-71. PubMed ID: 23085739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of "Physiologically Based Pharmacokinetic Model (PBPK)" New Approach Methodology (NAM) in Pharmaceuticals and Environmental Chemical Risk Assessment.
    Deepika D; Kumar V
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model.
    Kim SJ; Choi EJ; Choi GW; Lee YB; Cho HY
    Arch Toxicol; 2019 Feb; 93(2):311-330. PubMed ID: 30483840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic reanalysis of a Diazepam PBPK model: a comparison of Stan and GNU MCSim.
    Tsiros P; Bois FY; Dokoumetzidis A; Tsiliki G; Sarimveis H
    J Pharmacokinet Pharmacodyn; 2019 Apr; 46(2):173-192. PubMed ID: 30949914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
    Chou WC; Lin Z
    Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.